This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
Berkeley Group ups FY19 pre-tax profit guidance by 5%+, reiterates guidance for next 2 years; NAV +8%, net cash +25%; Forward sales -14%; £280m per annum in buybacks/divs extended to 2025. Good start to year, short term outlook uncertain on Brexit + other headwinds in London/SE.
AB Foods 8-week sales and profits in-line. FY guidance unchanged. November Primark trading challenging. Expects Grocery profits growth after higher Aus/UK margins, sees Sugar profits significantly lower due to effect of EU sugar prices.
AstraZeneca’s Imfinzi cancer treatment misses Phase III EAGLE trial primary end-point.
RELX completes £700m 2018 share buy-back; will buy back another £100m 2 Jan-18 Feb 2019
(Sources: Company newswires, Bloomberg, CNBC, FT, Reuters, Wall Street Journal)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| ROYAL MAIL | RMG | -0.4% | 3.2% | -1.1% |
| JUST EAT | JE/ | -7.0% | -2.8% | -8.8% |
| VODAFONE | VOD | -2.8% | -1.1% | -3.3% |
| DS SMITH | SMDS | -6.5% | -0.1% | -7.1% |
| TED BAKER | TED | 6.4% | 11.3% | 2.5% |
| FERREXPO | FXPO | 2.6% | 6.9% | 0.5% |
| BEAZLEY | BEZ | -5.9% | -1.7% | -5.9% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.
Prepared by Michael van Dulken, Head of Research